Idogen has signed a strategic collaboration agreement with two contract research organizations, Danish Klifo and Finnish 4Pharma, which will together with Idogen run the clinical phase 1/2a study with IDO 8. IDO 8 is a new cell therapy for patients with severe hemophilia who have developed antibodies to their treatment…
Nanoform Finland and Herantis Pharma have announced that they have signed a Biologics Proof of Concept Agreement for formulation Proof of Concept projects (PoCs) aiming to enhance nasal drug delivery to the brain of Herantis’ CDNF therapies for Parkinson’s disease using Nanoform’s biological nanoparticle technology. The agreed and non-exclusive collaboration…
A key executive for Birgmingham based Blodin Bioscience is a collaborator on a grant awarded by the Academy of Finland that will aid in the study of breast cancer therapies. The three year grant of $474,000 has been awarded to Dr. Johanna Tuomela at the University of Turku. Dr. Tuomela studies…
The Wisconsin Technology Innovation Initiative (Wi2) and Orion Corporation have announced a strategic collaboration in pursuit of new medicines for oncological diseases. Under the terms of the agreement, target proteins (modes of action) identified and initially validated at UW-Madison will be provided to Orion as a first step in establishing…